Jody Cain | Investor Relations |
John McLaughlin | Chief Executive Officer |
Dominique Monnet | President |
Peter Garcia | Chief Financial Officer |
Phil Nadeau | Cowen and Company |
Maxim Jacobs | Edison Group |
Welcome to the PDL BioPharma's Third Quarter 2018 Financial Results Conference Call. At this time all participants are in a listen-only mode.
Following management’s prepared remarks, we will hold a Q&A session. [Operator Instructions] As a reminder, this conference is being recorded November 06, 2018. I would now like to turn the conference over to Jody Cain.